Dogwood Therapeutics

DWTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$60.701 M

$1.81 +3.14%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$34.3M

Loss-making

Shares outstanding

33,401,553

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#341PMV PharmaceuticalsPMVP$63.5M
#342MindWalkHYFT$61.2M
#343Dogwood TherapeuticsDWTX$60.7M
#344Xilio TherapeuticsXLO$60.3M
#345IntercureINCR$58.0M

Where these numbers come from

Share counts and financials for Dogwood Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.